{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:11:21Z","timestamp":1791486681824,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.xops.2024.100566","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T13:16:54Z","timestamp":1718803014000},"page":"100566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Artificial Intelligence to Facilitate Clinical Trial Recruitment in Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5219-9312","authenticated-orcid":false,"given":"Dominic J.","family":"Williamson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert R.","family":"Struyven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6679-7276","authenticated-orcid":false,"given":"Fares","family":"Antaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried K.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Jhingan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8623-6684","authenticated-orcid":false,"given":"Zhichao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9441-4356","authenticated-orcid":false,"given":"Robyn","family":"Guymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7828-3122","authenticated-orcid":false,"given":"Simon S.","family":"Skene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naaman","family":"Tammuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9239-745X","authenticated-orcid":false,"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2024.100566_bib1","series-title":"Forum on drug Discovery, Development, and translation. Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary","year":"2010"},{"key":"10.1016\/j.xops.2024.100566_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","article-title":"The price of innovation: new estimates of drug development costs","volume":"22","author":"DiMasi","year":"2003","journal-title":"J\u00a0Health Econ"},{"key":"10.1016\/j.xops.2024.100566_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002360","article-title":"Methods to improve recruitment to randomised controlled trials: cochrane systematic review and meta-analysis","volume":"3","author":"Treweek","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.xops.2024.100566_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cct.2018.01.003","article-title":"Clinical trials recruitment planning: a proposed framework from the Clinical Trials Transformation Initiative","volume":"66","author":"Huang","year":"2018","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.xops.2024.100566_bib7","author":"Fultinavi\u010di\u016bt\u0117"},{"key":"10.1016\/j.xops.2024.100566_bib8","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2019.09.024","article-title":"Age-related macular degeneration preferred practice pattern","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100566_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2023-001395","article-title":"Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment","volume":"8","author":"Kaiser","year":"2023","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.xops.2024.100566_bib10","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.xops.2024.100566_bib11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2024.100566_bib12","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2024.100566_bib13","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(23)01844-5","article-title":"Complement inhibitors for the treatment of geographic atrophy","volume":"402","author":"Chew","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2024.100566_bib14","first-page":"1064","article-title":"Complement inhibition for geographic atrophy: review of salient functional outcomes and perspective","volume":"43","author":"Spaide","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.xops.2024.100566_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.survophthal.2023.11.008","article-title":"The effect of complement C3 or C5 inhibition on geographic atrophy secondary to age-related macular degeneration: a living systematic review and meta-analysis","volume":"69","author":"Garg","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2024.100566_bib16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.oret.2017.08.018","article-title":"Design characteristics of geographic atrophy treatment trials: systematic review of registered trials in ClinicalTrials.gov","volume":"2","author":"Cheng","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2024.100566_bib17","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/s41433-022-02095-2","article-title":"The Royal College of Ophthalmologists Commissioning guidelines on age macular degeneration: executive summary","volume":"36","author":"Chandra","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.xops.2024.100566_bib18","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial","volume":"37","author":"Patel","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.xops.2024.100566_bib19","first-page":"1500","article-title":"Efficacy of intravitreal pegcetacoplan in patients with geographic atrophy (GA): 12-month results from the phase 3 OAKS and DERBY studies","volume":"63","author":"Goldberg","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2024.100566_bib20","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2023.23822","article-title":"The future of clinical trials: artificial to augmented to applied intelligence","volume":"330","author":"Hernandez","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.xops.2024.100566_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109092","article-title":"Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials","volume":"220","author":"Yaghy","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2024.100566_bib22","series-title":"English indices of deprivation 2019","year":"2019"},{"key":"10.1016\/j.xops.2024.100566_bib23","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","article-title":"Clinically applicable deep learning for diagnosis and referral in retinal disease","volume":"24","author":"De Fauw","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.xops.2024.100566_bib24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100566_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev-vision-111022-123909","article-title":"What is a preferred retinal locus?","volume":"9","author":"Tarita-Nistor","year":"2023","journal-title":"Annu Rev Vis Sci"},{"key":"10.1016\/j.xops.2024.100566_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s13063-021-05397-0","article-title":"The use of electronic health records for recruitment in clinical trials: a mixed methods analysis of the Harmony Outcomes Electronic Health Record Ancillary Study","volume":"22","author":"O'Brien","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.xops.2024.100566_bib31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.xops.2024.100566_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/OPTH.S367089","article-title":"Emerging treatment options for geographic atrophy (GA) secondary to age-related macular degeneration","volume":"17","author":"Khan","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xops.2024.100566_bib33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1037\/1040-3590.6.4.284","article-title":"Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology","volume":"6","author":"Cicchetti","year":"1994","journal-title":"Psychol Assess"},{"key":"10.1016\/j.xops.2024.100566_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.oret.2022.03.017","article-title":"Correlation between fundus autofluorescence and en face OCT measurements of geographic atrophy","volume":"6","author":"Velaga","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2024.100566_bib35","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/IAE.0b013e31829c3765","article-title":"Outer retinal atrophy after regression of subretinal drusenoid deposits as a newly recognized form of late age-related macular degeneration","volume":"33","author":"Spaide","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.xops.2024.100566_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jamaophthalmol.2021.0857","article-title":"Racial\/ethnic disparities in ophthalmology clinical trials resulting in US food and drug administration drug approvals from 2000 to 2020","volume":"139","author":"Berkowitz","year":"2021","journal-title":"JAMA Ophthalmol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914524001027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914524001027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T04:02:57Z","timestamp":1732680177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914524001027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2666914524001027"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2024.100566","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.15.24302891","asserted-by":"object"}]},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial Intelligence to Facilitate Clinical Trial Recruitment in Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2024.100566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100566"}}